Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Pleven – page 24

297 clinical trials in Pleven, Bulgaria across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Pleven at a glance
297
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

297 trials in Pleven

Open in trial search
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Naproxen
  • Sponsor:Charite Universitaetsmedizin Berlin KöR
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Chlorambucil
  • Sponsor:F. Hoffmann-La Roche AG
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Hhalpc
  • Sponsor:Cellaïon SA

Embolism

Not recruiting
Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.

Colitis ulcerative

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Hidradenitis

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Spesolimab
  • Sponsor:Boehringer Ingelheim Espana S.A.

Colitis ulcerative

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Dermatitis atopic

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Ulotaront
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Diroximel Fumarate
  • Sponsor:Biogen Idec Research Limited
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Gadobutrol
  • Sponsor:Bayer AG

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Pleven

What the registry says about research in the country

01 Respiratory Health

Innovative research focusing on viral respiratory infections, including studies of vaccines against RSV, human metapneumovirus, and influenza in older adults. Clinical trials aim to enhance protection against severe respiratory diseases.

  • RSV and hMPV Prevention
  • Influenza Vaccine Development
  • Viral Lung Infection Treatment

Emphasis on vaccine efficacy and immune response in vulnerable populations.

02 Dermatological Conditions

Comprehensive studies addressing various skin conditions, with particular focus on psoriasis and hidradenitis suppurativa. Research includes both systemic and targeted therapies.

  • Plaque Psoriasis Management
  • Hidradenitis Suppurativa Treatment
  • Genital Psoriasis Therapy

Innovative approaches in chronic skin condition management.

03 Cardiovascular Research

Advanced studies in cardiovascular disease prevention and treatment, including investigations into heart failure prevention and lipid management strategies.

  • Heart Failure Prevention
  • Lipoprotein Management
  • Cardiovascular Risk Reduction

Focus on preventive strategies and innovative therapeutic approaches.

04 Autoimmune Disorders

Investigations into various autoimmune conditions, including multiple sclerosis and Sjögren's disease, exploring new therapeutic options and treatment approaches.

  • Multiple Sclerosis Treatment
  • Sjögren's Disease Management
  • Inflammatory Disease Therapy

Emphasis on improving quality of life for patients with chronic conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.